OTC · VVCIF
VIVO Cannabis Inc.
$0.02+$0.00 (+4.79%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.5% below the high.
Loading market information…
OTC · NDVAF · USD
Stock price, earnings
Quote as of Jun 13, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Indiva Limited’s quoted price sits in the upper half of its reported 52-week range, 4.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Indiva Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Indiva Limited is a Canadian enterprise focused on the cultivation, processing, and distribution of cannabis and its related merchandise across the country. The company offers an array of cannabis products, including pre-rolled joints, dried flower, capsules, and various edibles and extracts, primarily marketed under its own INDIVA and Artisan Batch brands. In addition to its proprietary offerings, Indiva provides manufacturing and production services to other businesses within the industry. Through strategic licensing agreements and partnerships, it also manufactures and distributes well-known third-party products like Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Grön edibles, and Dime Industries vape products. The firm's main operational base is located in Ottawa, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $5.85M-19.09% vs estimate |
| Q2 2022 | Aug 16, 2022 | -$0.02-157.73% vs estimate | $6.31M-15.35% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.02+$0.00 (+4.79%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.5% below the high.
A$0.02-A$0.00 (-4.76%)
Epsilon Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00+$0.00 (+14.94%)
China Infrastructure Construction Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.12+$0.00 (+2.52%)
Acreage Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.06% below the high.
$1.50$0.00 (0.0%)
Pixium Vision S.A.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00+$0.00 (+9,900.0%)
Invictus MD Strategies Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$3.25+$0.03 (+0.93%)
Guardion Health Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.94% below the high.
$0.00+$0.00 (+40.0%)
Heritage Cannabis Holdings Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
